Perigon Wealth Management LLC Has $2.98 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Perigon Wealth Management LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 3.6% in the 4th quarter, HoldingsChannel reports. The firm owned 33,677 shares of the company’s stock after acquiring an additional 1,184 shares during the period. Perigon Wealth Management LLC’s holdings in Colgate-Palmolive were worth $2,982,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth approximately $64,000. Finally, True Wealth Design LLC lifted its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $89.92 on Wednesday. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business has a fifty day simple moving average of $91.74 and a two-hundred day simple moving average of $97.40. The company has a market capitalization of $73.47 billion, a P/E ratio of 25.77, a P/E/G ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CL. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. UBS Group decreased their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Finally, Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.